Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Add-on vs Monotherapy in Epilepsy (TEAMS)
NCT01627860Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of topiramate in epilepsy, sponsored by Johnson & Johnson. Started Feb 2010; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01627860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627860.